The Ca2+ channel and 5-HT2 receptor antagonist (s)-emopamil in cerebral ischaemia
- 30 June 1989
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 10 (6) , 215-217
- https://doi.org/10.1016/0165-6147(89)90262-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Focal Cerebral Ischaemia in the Cat: Treatment with the Glutamate Antagonist MK-801 after Induction of IschaemiaJournal of Cerebral Blood Flow & Metabolism, 1988
- A Controlled Trial of Nimodipine in Acute Ischemic StrokeNew England Journal of Medicine, 1988
- Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damageTrends in Neurosciences, 1988
- Effects of Cerebroprotective Agents on Cerebral Blood Flow and on Postischemic Energy Metabolism in the Rat BrainJournal of Cerebral Blood Flow & Metabolism, 1987
- Effects of Calcium Entry Blocker Emopamil on Postischemic Energy Metabolism of the Isolated Perfused Rat BrainJournal of Cerebral Blood Flow & Metabolism, 1987
- Thrombolysis and StrokeArchives of Neurology, 1987
- Effect of flunarizine on global brain ischemia in the dog: A quantitative morphologic assessmentExperimental Neurology, 1987
- Flunarizine, a Calcium Entry Blocker, Ameliorates Ischemic Brain Damage in the RatAnesthesiology, 1986
- Improved short-term neurological recovery with flunarizine in a canine model of cardiac arrestThe American Journal of Emergency Medicine, 1985
- Failure of flunarizine to improve cerebral blood flow or neurologic recovery in a canine model of complete cerebral ischemia.Stroke, 1984